SMTI

Sanara MedTech Inc.

NasdaqAdd to watchlist

Healthcare · Medical Instruments & Supplies

$34.57

−$0.01−0.03%

Delayed · 2026-08-28T20:00:00.000Z · marketstack

Aug 24, 2026$34.57

+$0.19+0.55%over 1M

Session

Day range37% of range

$34.46$34.76

Fundamentals

Visualize fundamentals and more

Market cap: 299.47M
P/E ratio: -

Revenue grew +18.97% in FY2025, +10.11% faster than its sector. The median across Healthcare companies this platform tracks is +8.87%.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2025.

FDA approval
Reimbursement
Product recalls
Litigation
Debt covenants
Export controls
Commodity prices
Key people

And 12 more.

FDA approval
We and our research and development partners responsible for manufacturing certain of our products and their contract manufacturers are obliged to operate in accordance with FDA’s current good manufacturing practices (“cGMP”), current good tissue practices …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Recent activity

17 more events are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Updated Aug 28, 2026 · the last close

Sanara MedTech Inc. investor relations

What SMTI has filed with the SEC. This is not Sanara MedTech Inc.’s own investor relations site: these filings are the primary source that site publishes from.

Companies like Sanara MedTech Inc.

Also filed under Medical Instruments & Supplies, ranked by how closely they sit beside SMTI.

ISRGIntuitive Surgical Inc.compare with SMTI
BDXBecton Dickinson & Co.compare with SMTI
COO

What an account lets you do with Sanara MedTech Inc.

Be told the moment a SMTI insider trades
Put Sanara MedTech Inc. on a watchlist for a free alert, the bell and a daily email, when a Form 4 worth a row is filed, with vesting and automatic tax sales already struck out so what lands is a decision, not paperwork.
The full filing historyMeasure
Ask what growth the price is already betting on
Sanara MedTech Inc.'s income statement, balance sheet and cash flow as filed, and the ratios computed from them, plus a reverse DCF that holds today's price fixed and solves for the growth it requires.
The reverse DCFMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: how big a bet each one is, and by how much it changed.
Every position, sizedMeasure
Interrogate the filing, not the internet
Ask anything about Sanara MedTech Inc.'s fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free account See what the paid plans add

Free, no card, and it does not expire.

What it says it is exposed to

From Item 1A of its most recent 10-K, filed March 2025.

FDA approval
Reimbursement
Product recalls
Litigation
Debt covenants
Export controls
Commodity prices
Key people

And 12 more.

FDA approval
We and our research and development partners responsible for manufacturing certain of our products and their contract manufacturers are obliged to operate in accordance with FDA’s current good manufacturing practices (“cGMP”), current good tissue practices …

7 more themes are on Measure

Measure Create a free account

Free, no card, and it does not expire. See what the paid plans add

Session

Fundamentals

What it says it is exposed to

Recent activity

Discussion

Sanara MedTech Inc. investor relations

Companies like Sanara MedTech Inc.

Ask about Sanara MedTech Inc.

What an account lets you do with Sanara MedTech Inc.

What it says it is exposed to

Recent activity